REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
47,237,181
Share change
+795,844
Total reported value
$13,643,742,113
Put/Call ratio
185%
Price per share
$288.99
Number of holders
472
Value change
+$286,277,453
Number of buys
219
Number of sells
206

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2021

As of 30 Sep 2021, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 472 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,237,181 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., FRED ALGER MANAGEMENT, LLC, STATE STREET CORP, WCM INVESTMENT MANAGEMENT, LLC, Select Equity Group, L.P., ALLIANCEBERNSTEIN L.P., and FRANKLIN RESOURCES INC. This page lists 472 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.